Roche Diagnostics France and PrimaDiag Join Together to Propose an Automated Solution for the Capture of Exomes for Sequencing

Roche Diagnostics France and PrimaDiag announced they have concluded a joint promotion agreement whose aim is to propose an automation solution for Roche’s capture of exomes sequencing product range NimbleGen with PrimaDiag’s automation platform ACSIA NGS^CaptureEdition.

This agreement is the result of the combined expertises of the two companies, PrimaDiag offers, on one hand, automation of protocole solutions in the field of molecular biology and on the other hand, Roche Diagnostics France furnishes its’ method for liquid phase sequence capturing allowing for the enrichment of genomic regions of interest.

The automation solution on the ACSIA NGSCapture Edition platform is possible for the capture of exomes for all the sequencing products in the NimbleGen SeqCap Enrichment System (EZ, Epi, RNA) product range and for the preparation of samples for exomes libraries . The automation allows the capture from 1 to 48 samples and increases productivity while decreasing the quantity of reagents and consumables that are used during the different steps of a protocol. The automation of the capture of exomes for sequencing reduces the risks of error during the manipulation of the tubes of reagents while increasing the reproducibility of inter-samples. The flow is thus increased and the costs of sequencing are decreased.

“Working with Roche Diagnostics France on the automation of the NimbleGen SeqCap kits is a unique opportunity for PrimaDiag. The quality of Roche’s NimbleGen products is a natural fit with PrimaDiag’s desire to show the efficiency of its ACSIA products solutions as well as the expertise of their respective teams.

The result of this partnership is the development of automation methods which respect and optimize the intrinsic qualities of the NimbleGen kits.

Through this partnership, Roche Diagnostics France and PrimaDiag put within the reach of all the laboratories an automated solution of high quality for the capture of exomes for sequencing” declared Grégory Meunier, General Manager, PrimaDiag.

“By combining our Roche NimbleGen capture of exomes for sequencing solutions with PrimaDiag’s line of ASCIA automated platforms, we allow researchers to respond to the increased number of samples to be analyzed and also to the increased of the number of genes to be studied and to be detected by sequencing”. Carole Donne-Goussé, Product Manager, Roche Sequencing.

Thanks to this collaboration, this complete and successful solution will allow customers to benefit from a flexible and simplified workflow.